Abstract
The vagina, in addition to being a genital organ with functions related to conception, serves as a potential route for drug administration. Mainly used for local action in the cervico-vaginal region, it has the potential of delivering drugs for systemic effects and uterine targeting. Within recent years the level of interest in both local and systemic vaginal drug delivery systems has increased considerably. The vagina offers numerous advantages as a site for drug delivery, such as convenient access, prolonged retention of formulations, a great permeation area, high vascularization, relatively low enzymatic activity, and the avoidance of first-pass metabolism. Currently available vaginal dosage forms have several limitations, such as leakage and messiness necessitating the need to develop novel drug delivery systems. The purpose of writing this review was to compile the recent literature on novel vaginal drug delivery systems.
Keywords: Novel vaginal delivery systems, polymers, drugs used in vaginal delivery
Current Drug Therapy
Title: Novel Vaginal Drug Delivery Systems: A Review
Volume: 5 Issue: 2
Author(s): Umme Hani, R. Sudeendra Bhat, Ritesh Sisodiya and Hosakote Gurumallappa Shivakumar
Affiliation:
Keywords: Novel vaginal delivery systems, polymers, drugs used in vaginal delivery
Abstract: The vagina, in addition to being a genital organ with functions related to conception, serves as a potential route for drug administration. Mainly used for local action in the cervico-vaginal region, it has the potential of delivering drugs for systemic effects and uterine targeting. Within recent years the level of interest in both local and systemic vaginal drug delivery systems has increased considerably. The vagina offers numerous advantages as a site for drug delivery, such as convenient access, prolonged retention of formulations, a great permeation area, high vascularization, relatively low enzymatic activity, and the avoidance of first-pass metabolism. Currently available vaginal dosage forms have several limitations, such as leakage and messiness necessitating the need to develop novel drug delivery systems. The purpose of writing this review was to compile the recent literature on novel vaginal drug delivery systems.
Export Options
About this article
Cite this article as:
Hani Umme, Bhat R. Sudeendra, Sisodiya Ritesh and Gurumallappa Shivakumar Hosakote, Novel Vaginal Drug Delivery Systems: A Review, Current Drug Therapy 2010; 5(2) . https://dx.doi.org/10.2174/157488510791065067
DOI https://dx.doi.org/10.2174/157488510791065067 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Peptides as Potential Drugs for Cancer Therapy
Current Pharmaceutical Design CC and CXC Chemokines in Breastmilk are Associated with Mother-to- Child HIV-1 Transmission
Current HIV Research Insects Antiviral and Anticancer Peptides: New Leads for the Future?
Protein & Peptide Letters Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Accessing Cancer Metabolic Pathways by the Use of Microarray Technology
Current Pharmaceutical Design Patent Selections:
Recent Patents on Medical Imaging Electroporation: An Effective Method For <i>In Vivo</i> Gene Delivery
Drug Delivery Letters CDK Inhibitors Induce Mitochondria-mediated Apoptosis Through the Activation of Polyamine Catabolic Pathway in LNCaP, DU145 and PC3 Prostate Cancer Cells
Current Pharmaceutical Design From TGF-β to Cancer Therapy
Current Drug Targets Anticancer Immunotherapy in Combination with Proapoptotic Therapy
Current Cancer Drug Targets Integrins and Cancer: Gene Expression, Epigenetics and Metastasis
Current Genomics Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes
Current Radiopharmaceuticals